This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting central nervous system disorders. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications, where the (S)-enantiomer is crucial for therapeutic efficacy. Additionally, it finds application in research settings for studying receptor-ligand interactions and developing novel compounds with potential therapeutic benefits. Its stability and solubility in aqueous solutions make it suitable for use in both laboratory and industrial-scale processes.